Efficacy and Safety of Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials
Background: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for advanced non-small cell lung cancer (NSCLC). This systematic review synthesizes the evidence from randomized controlled trials (RCTs) to evaluate the efficacy and safety of ICI-based therapies compared to chemotherapy. Metho...